Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Ajora P, Avery CL, et al. AHA Statistical Update: 2024 heart disease and stroke statistics: A report of US and global data from the American Heart Association. Circulation. 2024;149:e347–913. https://doi.org/10.1161/CIR.0000000000001209.

Article  PubMed  Google Scholar 

Steen DL, Khan I, Andrade K, Koumas A, Giugliano RP. Event rates and risk factors for recurrent cardiovascular events and mortality in a contemporary post-acute coronary syndrome population representing 239,234 patients during 2005 to 2018 in the United States. J Am Heart Assoc. 2022;11:e022198. https://doi.org/10.1161/JAHA.121.022198.

Article  PubMed  PubMed Central  Google Scholar 

United States Census Bureau. Older Population and Aging. In: https://www.census.gov/topics/population/older-aging.html. Accessed 15 June 2024.

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139:e1082–143. https://doi.org/10.1161/CIR.0000000000000625.

Article  PubMed  Google Scholar 

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas K, Back M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–337. https://doi.org/10.1093/eurheartj/ehab484.

Article  PubMed  Google Scholar 

The ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attach Trial (ALLHAT-LLT). JAMA 2002; 288: 2998–3007. https://doi.org/10.1001/jama.288.23.2998.

Han BH, Sutin D, Williamson JD, Davis BR, Piller LB, Pervin H, et al. Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults. The ALLHAT-LLT randomized clinical trial. JAMA Intern Med. 2017;177:955–65. https://doi.org/10.1001/jamainternmed.2017.1442.

Article  PubMed  PubMed Central  Google Scholar 

Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet. 2002;360:1623–30. https://doi.org/10.1016/S0140-6736(02)11600-X.

Article  CAS  PubMed  Google Scholar 

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New Engl J Med. 2008;359:2195–207. https://doi.org/10.1056/NEJMoa0807646.

Article  CAS  PubMed  Google Scholar 

Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374:2021–31. https://doi.org/10.1056/NEJMoa1600176.

Article  CAS  PubMed  Google Scholar 

Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S. Primary prevention with statin therapy in the elderly: new meta-analyses from the contemporary JUPITER and HOPE-3 randomized trials. Circulation. 2017;135:1979–81. https://doi.org/10.1161/CIRCULATIONAHA.117.028271.

Article  PubMed  Google Scholar 

Xu W, Lee AL, Lam CLK, Danaei G, Wan EYF. Benefits and risks associated with statin therapy for primary prevention in old and very old adults: real-world evidence from a target trial emulation study. Ann Intern Med. 2024;177(6):701–10. https://doi.org/10.7326/M24-0004.

Article  PubMed  Google Scholar 

Cholesterol Treatment Trialists’ Collaboration. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomized controlled trials. The Lancet. 2019;393:407–15. https://doi.org/10.1016/S0140-6736(18)31942-1.

Article  Google Scholar 

Awad K, Mohammed M, Zaki MM, et al. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observation studies. BMC Med. 2021;19:139. https://doi.org/10.1186/s12916-021-02009-1.

Article  PubMed  PubMed Central  Google Scholar 

Zoungas S, Curtis A, Spark S, Wolfe R, McNeil JJ, Beilin L, et al. Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial). BMJ Open. 2023;13:e069915. https://doi.org/10.1136/bmjopen-2022-069915.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen QD, Odden MC, Peralta CA, Kim DH. Predicting risk of atherosclerotic cardiovascular disease using pooled cohort equations in older adults with frailty, multimorbidity, and competing risks. J Am Heart Assoc. 2020;9(18):e016003. https://doi.org/10.1161/JAHA.119.016003.

Article  PubMed  PubMed Central  Google Scholar 

Defilippi CR, De Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304(22):2494. https://doi.org/10.1001/jama.2010.1708.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saunders JT, Nambi V, De Lemos JA, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation. 2011;123(13):1367–76. https://doi.org/10.1161/circulationaha.110.005264.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350(7):655–63. https://doi.org/10.1056/nejmoa031994.

Article  CAS  PubMed  Google Scholar 

Burger PM, Pradhan AD, Dorresteijn JAN, et al. C-reactive protein and risk of cardiovascular events and mortality in patients with various cardiovascular disease Locations. Am J Cardiol. 2023;197:13–23. https://doi.org/10.1016/j.amjcard.2023.03.025.

Article  CAS  PubMed  Google Scholar 

Qureshi WT, Rana JS, Yeboah J, Bin Nasir U, Al-Mallah MH. Risk stratification for primary prevention of coronary artery disease: roles of C-reactive protein and coronary artery calcium. Curr Cardiol Rep. 2015;17(12):110. https://doi.org/10.1007/s11886-015-0666-9.

Article  PubMed  Google Scholar 

Budoff MJ, Mcclelland RL, Nasir K, et al. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2009;158(4):554–61. https://doi.org/10.1016/j.ahj.2009.08.007.

Article  PubMed  PubMed Central  Google Scholar 

Budoff MJ, Young R, Burke G, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018;39(25):2401–8. https://doi.org/10.1093/eurheartj/ehy217.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gore MO, Ayers CR, Khera A, et al. Combining biomarkers and imaging for short-term assessment of cardiovascular disease risk in apparently healthy adults. J Am Heart Assoc. 2020;9(15):e015410. https://doi.org/10.1161/jaha.119.015410.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saeed A, Nambi V, Sun W, et al. Short-term global cardiovascular disease risk prediction in older adults. J Am Coll Cardiol. 2018;71(22):2527–36. https://doi.org/10.1016/j.jacc.2018.02.050.

Article  PubMed  PubMed Central  Google Scholar 

Mortensen MB, Fuster V, Muntendam P, et al. A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage study. J Am Coll Cardiol. 2016;68(9):881–91. https://doi.org/10.1016/j.jacc.2016.05.084.

Article  PubMed  Google Scholar 

Heart Protection Study Collaborative Group. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet. 2011;378(9808):2013–20. https://doi.org/10.1016/S0140-6736(11)61125-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Afilalo J, Duque G, Steele R, Jukema JW, de Craen AJ, Eisenberg MJ. Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J Am Coll Cardiol. 2008;51(1):37–45.

Article  CAS  PubMed  Google Scholar 

Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–81. https://doi.org/10.1016/S0140-6736(10)61350-5.